Intralesional cyclosporin in psoriasis
Powles, A.V.; Baker, B.S.; McFadden, J.P.; Valdimarsson, H.; Fry, L.
Acta Dermato-Venereologica. Supplementum 146 148-149; Discussion: 149-150
1989
ISSN/ISBN: 0365-8341 PMID: 2609857 Document Number: 343287
Document emailed within 1 workday
Related Documents
Ippolito, F.; Di Carlo, A.; Carducci, M.; Leone, G.; Frascione, P. 1989: Cyclosporin a and psoriasis: a thermographic study Acta Dermato-Venereologica. Supplementum 146: 155-158Levell, N.J.; Shuster, S.; Munro, C.S.; Friedmann, P.S. 1995: Remission of ordinary psoriasis following a short clearance course of cyclosporin Acta Dermato-Venereologica 75(1): 65-69
Harvima, R.J.; Laukkanen, A.; Haring, P.; Rinne, K. 1999: Generalized pustular psoriasis during pregnancy: an effective treatment with cyclosporin Duodecim; Laaketieteellinen Aikakauskirja 115(4): 391-395
Frappaz, A.; Haftek, H.; Thivolet, J. 1989: Long-term treatment of severe psoriasis with low-dose cyclosporin: (2.5 mg/kg/day to 5 mg/kg/day) Acta Dermato-Venereologica. Supplementum 146: 147
Edwards, B.D.; Chalmers, R.J.; O'Driscoll, J.B.; Mitchell, D.M.; Smith, R.J.; Lawson, R.S.; Testa, H.J.; Ballardie, F.W. 1994: Angiotensin Ii as a risk factor for cyclosporin nephrotoxicity in patients with psoriasis Clinical Nephrology 41(6): 350-356
Ieiri, I.; Nakayama, J.; Murakami, H.; Hori, Y.; Higuchi, S. 1996: Evaluation of the therapeutic range of whole blood cyclosporin concentration in the treatment of psoriasis International Journal of Clinical Pharmacology and Therapeutics 34(3): 106-111
Jan, V.; Vaillant, L.; Bressieux, J.M.; Barthélemy, H.; Legoux, A.; Steiner, H.G.; Reigneau, O. 1999: Short-term cyclosporin monotherapy for chronic severe plaque-type psoriasis European Journal of Dermatology: Ejd 9(8): 615-617
Gunn, H.C.; Ryffel, B. 1986: Successful treatment of autoimmunity in (NZB X NZW)F1 mice with cyclosporin and (Nva2)-cyclosporin: II. Reduction of glomerulonephritis Clinical and Experimental Immunology 64(2): 234-242
Sabaté, I.; Griñó, J.; Castelao, A.M.; Ortolá, J. 1988: Evaluation of cyclosporin-verapamil interaction, with observations on parent cyclosporin and metabolites Clinical Chemistry 34(10): 2151
Kroczek, R.A.; Black, C.D.; Barbet, J.; Shevach, E.M. 1987: Mechanism of action of cyclosporin A in vivo. I. Cyclosporin A fails to inhibit T lymphocyte activation in response to alloantigens Journal of Immunology 139(11): 3597-3603
Felder, R.A.; Mifflin, T.E.; Bastani, B. 1986: An optimized method for measuring cyclosporin a with 125I-labeled cyclosporin Clinical Chemistry 32(7): 1378-1382
Lipkin, G.W.; Tucker, B.; Giles, M.; Raine, A.E. 1993: Ambulatory blood pressure and left ventricular mass in cyclosporin- and non-cyclosporin-treated renal transplant recipients Journal of Hypertension 11(4): 439-442
Kosugi, A.; Sharrow, S.O.; Shearer, G.M. 1989: Effect of cyclosporin A on lymphopoiesis. I. Absence of mature T cells in thymus and periphery of bone marrow transplanted mice treated with cyclosporin A Journal of Immunology 142(9): 3026-3032
Turco, G.; Ferrari Parabita, S.; Sacco, M.; Re, G. 1988: Hypertrophic gingivitis caused by cyclosporin A. 30 months' clinical experience in the use of cyclosporin a in patients undergoing cadaver kidney transplantation, with special attention to the proven side effects at the gingival level Minerva Stomatologica 37(12): 1043-1050
Ochiai, T.; Naito, K.; Murakami, O.; Ohno, K.; Sekita, K.; Furuya, T.; Kurokawa, Y.; Matsumoto, K.; Saito, Y.; Hachisuka, A. 1993: Evaluation of immunotoxicity tests using cyclosporin A-treated rats: the International Collaborative Immunotoxicity Study II (cyclosporin A) Eisei Shikenjo Hokoku. Bulletin of National Institute of Hygienic Sciences 1993(111): 91-99
Vickers, A.E.; Fisher, R.L.; Brendel, K.; Guertler, J.; Dannecker, R.; Keller, B.; Fischer, V. 1995: Sites of biotransformation for the cyclosporin derivative SDZ IMM 125 using human liver and kidney slices and intestine. Comparison with rat liver slices and cyclosporin a metabolism Drug Metabolism and Disposition: the Biological Fate of Chemicals 23(3): 327-333
Miemiec, E. 1970: Quantitative determination of IgM in serum of patients with psoriasis vulgaris with respect to psoriasis arthropathica Dermatologische Monatschrift 156(5): 490-492
Bonomo, L.; Abittan, B.J..; Hashim, P.W..; Karki, C.; Mason, M.; Lebwohl, M. 2019: Combination use of Systemic Therapies in Psoriasis: Baseline Characteristics from the Corrona Psoriasis Registry Journal of Drugs in Dermatology: Jdd 18(8): 731-740
Hellgren, L. 1976: Induction of generalized pustular psoriasis by topical use of betamethasone-dipropionate ointment in psoriasis Annals of Clinical Research 8(5): 317-319
Kwan, Z.; Yeoh, C.A.; Mohd Affandi, A.; Alias, F.A.; Hamid, M.; Baharum, N.; Yong, A.S.W.; Baba, R. 2015: Causes of mortality in patients with psoriasis in Malaysia - Evidence from the Malaysian Psoriasis Registry Medical Journal of Malaysia 70(5): 273-277